Page 44 - Options Segment News Today

Recommendation: Reduce; Target Price: Rs 208

Currently, Envafolimab is being developed in the USA by Tracon Pharma in a pivotal trial for soft tissue sarcoma (STS) subtypes

As we look towards the upcoming Interim Budget 2024, we expect the honourable Finance Minister Nirmala Sitharaman will revisit GST rates on the vital spare parts of the EVs

The subsidy is subject to criteria, including a Rs 1.5 lakh limit on the ex-factory price for two-wheelers

Recommendation: Add; Target price: Rs 235

While the midcap indices showed corrections parallel to the benchmarks, the smallcap indices outperformed, with Nifty Smallcap concluding higher by 0.5%.

Vi postpaid mobile users can now access Swiggy One Membership, valued at over Rs 2500, at no additional cost.

Cult.fit is also realigning its business approach to become an offline-heavy gym firm.

Recommendation: Reduce; Target price: Rs 5850

Subdued performance expected from the company.